Table 2 The percentages of circulating macrophage subsets in patients with breast cancer and the healthy controls
From: Altered monocyte differentiation and macrophage polarization patterns in patients with breast cancer
Subsets | PM2 K+ cells | PM2 K+CD14+ cells | PM2 K+CD14− cells | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
PM2 K+CD14+ | PM2 K+CD14− | M1 | M2a | M2b | M2c | M1 | M2a | M2b | M2c | |
Control (%, mean ± SD) | 1.37 ± 1.26 | 0.37 ± 0.47 | 73.24 ± 30.54 | 1.72 ± 2.23 | 1.25 ± 3.02 | 1.23 ± 1.80 | 32.46 ± 34.81 | 7.92 ± 14.32 | 3.66 ± 9.27 | 2.86 ± 8.85 |
Breast Cancer (%, mean ± SD) | 2.27 ± 1.93* | 1.79 ± 2.00* | 27.15 ± 29.93* | 17.12 ± 23.49* | 29.30 ± 31.30* | 26.63 ± 34.08* | 11.01 ± 13.08* | 11.31 ± 11.70 | 14.36 ± 17.98* | 17.88 ± 22.60* |
Aberrance in breast cancer | ↑ | ↑ | ↓ | ↑ | ↑ | ↑ | ↓ | n.s | ↑ | ↑ |